Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
DURABILITY II is the first controlled study to focus on treating long, complex lesions and to specifically test the performance of a single long stent in the superficial femoral artery. Read more about the DURABILITY II clinical study in these published, peer-reviewed journal articles.
DURABILITY II - primary 1 year
Matsumura JS, Yamanouchi D, et al. J Vasc Surg. 2013 Jul;58(1):73-83.
DURABILITY II - primary 3 year
Rocha-Singh KJ1, Bosiers M2, et al. Catheter Cardiovasc Interv. 2015 Jul;86(1):164-70.
DURABILITY II - gender 1 year
Tadros RO, Faries PL, et al. Ann Vasc Surg. 2014 Jan;28(1):1-9.
DURABILITY II - gender 3 year
Han DK, Faries PL, et al. Ann Vasc Surg. 2016 Jan;30:110-17.
DURABILITY 200 - long lesions
Bosiers M, Deloose K, et al. J Vasc Surg. October 2011, 54(4):1042-50.